𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cognitive impulsivity in Parkinson's disease patients: Assessment and pathophysiology

✍ Scribed by Gabriel Robert; Dominique Drapier; Marc Verin; Bruno Millet; Jean-Philippe Azulay; Olivier Blin


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
149 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Impulsivity may be induced by therapeutic interventions (dopamine replacement therapies and sub‐thalamic nucleus (STN) stimulation) in patients with Parkinson's disease (PD). The present review has two goals. First, to describe the most frequently encountered facets of cognitive impulsivity and to stress the links between cognitive impulsivity and aspects such as reward‐related decision making, risk‐taking, and time‐processing in healthy population. The most widely used related cognitive impulsivity paradigms are presented. Second, to review the results of studies on cognitive impulsivity in healthy volunteers and in patients with PD, the latter support the applicability and clinical relevance of this construct in PD population. Data show that PD treatments may favor impulsivity via different mechanisms. Suggestions on the roles of dopamine and STN in the pathophysiology of cognitive impulsivity are proposed. © 2009 Movement Disorder Society


📜 SIMILAR VOLUMES


Impulsivity and compulsivity in drug-naï
✍ Angelo Antonini; Chiara Siri; Gabriella Santangelo; Roberto Cilia; Michele Polet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## Background: Abnormal repetitive behaviors have been reported in Parkinson's disease (PD) during dopamine replacement therapy (DRT) and associated with individual predisposing features, including impulsivity. However, impulsivity and compulsive symptoms have never been explored in PD

Cognitive impairment in Parkinson's dise
✍ Jaime Kulisevsky; Javier Pagonabarraga 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract Cognitive impairment (CI) and dementia are frequent and debilitating features associated with Parkinson's disease (PD). Formal neuropsychological examination is required to ascertain the degree and pattern of CI over the course of the disease. The use of different tools may explain hete

Risk and learning in impulsive and nonim
✍ Atbin Djamshidian; Ashwani Jha; Sean S. O'Sullivan; Laura Silveira-Moriyama; Cla 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

## Abstract Relatively little is known about the interaction between behavioral changes, medication, and cognitive function in Parkinson's disease (PD). We examined working memory, learning and risk aversion in PD patients with and without impulsive or compulsive behavior (ICB) and compared the res

Assessing comorbidity in patients with P
✍ Martine Visser; Johan Marinus; Jacobus J. van Hilten; Ruth G.B. Schipper; Anne M 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

## Abstract The aim of this study was to assess the accuracy of an interview‐based assessment of comorbidity, in patients with Parkinson's disease (PD). The Cumulative Illness Rating Scale‐Geriatric (CIRS‐G) was completed (1) in an interview with 31 PD patients and their caregivers, and (2) by revi

Impulsive and compulsive behaviors in Pa
✍ Andrew H. Evans; Antonio P. Strafella; Daniel Weintraub; Mark Stacy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract Antiparkinson therapy can be the primary cause of a range of nonmotor symptoms that include a set of complex disinhibitory psychomotor pathologies and are linked by their repetitive, reward or incentive‐based natures. These behaviors relate to aberrant or excessive dopamine receptor sti

Cognitive dysfunctions and pathological
✍ Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Francesca Verde; Dario Gros 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract The purpose of this study was to investigate the neuropsychological correlates of pathological gambling (PG) in Parkinson's disease (PD). Fifteen patients with PD affected by PG (identified based on DSM‐IV criteria; PD+PG) without clinically evident dementia were compared with 15 nondem